A review of six placebo-controlled scientific trials with 1,134 overall individuals concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) were related to a greater ordinary improvement on the Ashworth scale for spasticity in numerous sclerosis patients when compared with placebo, Whi